DUBLIN, Ohio, Jan. 30 /PRNewswire-FirstCall/ -- Cardinal Health Chief Executive Officer of Clinical & Medical Products, David Schlotterbeck, will address investors at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference in New York on Feb. 7 at 9:20 a.m. Eastern Standard Time.
Mr. Schlotterbeck will discuss Cardinal Health's diverse products and services, company performance and strategies for continued growth. His remarks will be webcast live. To access the webcast, go to the Investors page at http://www.cardinalhealth.com. A transcript will also be available at http://www.cardinalhealth.com .
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $87 billion, global company serving the health care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market leading technologies, including Alaris(R) IV pumps, Pyxis(R) automated dispensing systems, MedMined(TM) infection surveillance services and the CareFusion(TM) patient identification system. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 19 on the Fortune 500 and No. 1 in its sector on Fortune's ranking of Most Admired firms, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at http://www.cardinalhealth.com.
|SOURCE Cardinal Health, Inc.|
Copyright©2008 PR Newswire.
All rights reserved